Milestone Pharmaceuticals Inc. (MIST) Operating cash flow 2018–2025
Milestone Pharmaceuticals Inc. (MIST) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$49.0MFY2025 · since FY2018: -$21.0M → -$49.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.0M | -70.0% |
| FY2024 | -$28.8M | +37.9% |
| FY2023 | -$46.4M | +11.5% |
| FY2022 | -$52.5M | -57.9% |
| FY2021 | -$33.2M | +34.5% |
| FY2020 | -$50.7M | +0.8% |
| FY2019 | -$51.2M | -143.0% |
| FY2018 | -$21.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice